American Gastroenterological Association Institute Guideline on Therapeutic Drug Monitoring in Inflammatory Bowel Disease.

نویسندگان

  • Joseph D Feuerstein
  • Geoffrey C Nguyen
  • Sonia S Kupfer
  • Yngve Falck-Ytter
  • Siddharth Singh
چکیده

Division of Gastroenterology and Center for Inflammatory Bowel Disease, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Mount Sinai Hospital Centre for Inflammatory Bowel Disease, University of Toronto, Toronto, Ontario, Canada; Division of Gastroenterology, The University of Chicago, Chicago, Illinois; Division of Gastroenterology and Liver Disease, Case Western Reserve University and Veterans Affairs Medical Center, Cleveland, Ohio; and Division of Gastroenterology, University of California, San Diego, La Jolla, California

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Therapeutic drug monitoring of tumor necrosis factor antagonists in inflammatory bowel disease.

Although tumor necrosis factor (TNF) antagonists have shown clear benefits over conventional treatments for inducing and maintaining clinical remission in both Crohn's disease and ulcerative colitis, a high proportion of patients lose response over time. Given the scarce alternative of treatments when treatment failure occurs, it is highly desirable to optimize both initial response and long-te...

متن کامل

American Gastroenterological Association Institute Guideline on the Medical Management of Microscopic Colitis.

Mount Sinai Hospital Centre for Inflammatory Bowel Disease, University of Toronto, Toronto, Ontario, Canada; Division of Gastroenterology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota; McMaster University, Hamilton, Ontario, Canada; and Evidence-Based Dentistry Unit, Faculty...

متن کامل

Application of extracellular vesicles in the treatment of inflammatory bowel disease

Introduction: Inflammatory bowel disease(IBD) is caused by genetic, environmental, microbial and immune factors. IBD has two primary forms: Ulcerative colitis and Crohn´s disease. The incidence of IBD has significantly increased over the last few decades. Given that patients have poor response to drug treatments or are resistant to drug therapies, new therapies are needed for gastrointestinal i...

متن کامل

Microscopic colitis: clinical and pathologic perspectives.

Microscopic colitis is a chronic inflammatory bowel disease characterized by chronic nonbloody diarrhea and specific histopathology features. Active disease, defined as 3 or more stools or 1 or more watery stools per day, significantly reduces quality of life. Epidemiologic studies have found the incidence and prevalence of microscopic colitis to be comparable with those of Crohn's disease and ...

متن کامل

Management of Clostridium difficile Infection in Inflammatory Bowel Disease: Expert Review from the Clinical Practice Updates Committee of the AGA Institute.

The purpose of this expert review is to synthesize the existing evidence on the management of Clostridium difficile infection in patients with underlying inflammatory bowel disease. The evidence reviewed in this article is a summation of relevant scientific publications, expert opinion statements, and current practice guidelines. This review is a summary of expert opinion in the field without a...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Gastroenterology

دوره 153 3  شماره 

صفحات  -

تاریخ انتشار 2017